Renewal filing window
- DaysBeforeExpiry
90
- Direction
no-earlier-than
- Applies to the product-registration documents covered by the Thai FDA renewal FAQ.
Explore the medical device requirements currently available for Thailand, organized by topic and linked to official sources.
What expires, what is retained periodically, and when must renewal start?
90
no-earlier-than
5
Fixed Term
Notification receipts (ใบรับจดแจ้ง) are valid for 5 years from the date shown on the receipt; renewal extends validity for a further 5 years (renewal FAQ).
Renewal applications are not accepted once more than one month has passed since expiry; within one month after expiry the holder may still apply for renewal together with a waiver request showing cause, paying the renewal fee.
Waiver clause seen verbatim: ผู้จดแจ้งซึ่งใบรับจดแจ้งของตนสิ้นอายุไม่เกินหนึ่งเดือน จะยื่นคาขอต่ออายุและขอผ่อนผันโดยแสดงเหตุผล...; it does not lift liability under มาตรา ๙๑.
Renewal applications are filed no more than 90 days before expiry; after the one-month post-expiry window a new process is required.
Does the event require internal documentation, notice, prior approval, transfer, or a new application?
Full CSDT
Other documents seen verbatim on the page: หนังสือยินยอมหรือรับรองให้มีการถ่ายโอนเอกสาร (Letter of Consent...); หนังสือรับรองแสดงความปลอดภัย (Safety Declaration).
Yes
30
Cancellation clause seen verbatim: เมื่อตำรับที่ขอถ่ายโอนเอกสารได้รับการอนุมัติ ทะเบียนตำรับแม่แบบจะถูกยกเลิก.
Where information already notified (จดแจ้อยู่) changes, the notifier must report the changed information to the licensing authority, following criteria, methods and conditions set by the authority.
Which manufacturer, representative, holder, applicant, importer, and distributor roles apply?
Registration Dossier Transfer With Consent
New Application Using Transferred Dossier
The transferee files a Full CSDT application; once it is approved the master registration is cancelled — transfer enables a new application rather than editing the holder field.
Corrected: baseline handover extras (new manufacturer LoA, complaints/recalls file, Thai labels, import inventory) are not listed on the official transfer page; handover trimmed to documents actually shown.
Medical-device importers must appoint an import controller (ผู้ควบคุมการนำเข้าเครื่องมือแพทย์) who holds at least a bachelor's degree and has a residence in Thailand.
Qualification items seen verbatim: 1. เป็นผู้ที่สำเร็จการศึกษาขั้นต่ำปริญญาตรี 2. มีถิ่นที่อยู่ในประเทศไทย.
Which current law, regulation, guidance, and transition provisions apply?
Medical Device Act B.E. 2551 (2008), as amended by Medical Device Act (No. 2) B.E. 2562 (2019), is the governing statute; the amendment took effect the day after its publication in the Royal Gazette (published 30 April 2019).
Gazette header: ราชกิจจานุเบกษา เล่ม ๑๓๖ ตอนที่ ๕๖ ก, ๓๐ เมษายน ๒๕๖๒.
Licences and detailed-listing receipts issued under the Medical Device Act B.E. 2551 before Act (No. 2) B.E. 2562 took effect remain valid until their expiry.
Is the product a device, IVD, accessory, software, or borderline product locally?
A medical device (เครื่องมือแพทย์) includes instruments, appliances, machines, objects inserted into the body, IVD reagents, products, software and other articles intended by the manufacturer/product owner for specified uses in humans or animals (diagnosis, prevention, monitoring, treatment, injury care, life support, etc.), and excludes articles whose principal action results from pharmacological, immunological or metabolic processes.
Exclusion clause seen verbatim: ต้องไม่เกิดจากกระบวนการทางเภสัชวิทยา วิทยาภูมิคุ้มกัน หรือปฏิกิริยาเผาผลาญให้เกิดพลังงานเป็นหลัก. PDF text shows น้ายา for น้ำยา (extraction artifact).
Which registration, notification, listing, reliance, or conformity route applies?
Route depends on the risk-based group of the device: licence route (ขออนุญาต, ใบอนุญาต), detailed-notification route (แจ้งรายการละเอียด, ใบรับแจ้งรายการละเอียด), or notification route (จดแจ้ง, ใบรับจดแจ้ง); applied for by the registered manufacturer or importer.
The provision's third group (ค) กลุ่มเครื่องมือแพทย์หรือเครื่องมือแพทย์ที่ผู้ผลิตหรือผู้นาเข้าต้องจดแจ้อยู่ในบทเดียวกัน completes the three routes.
Thai FDA accepts three submission tracks: Full evaluation (CSDT dossier), Abridged (device already registered for at least 1 year by a Big-5 reference agency), and Reliance (Singapore HSA registration with registrant consent).
Which foreign decisions or evidence can be reused, with what effect and conditions?
geo:tha
Australia TGA/ARTG market authorization evidence
Abridged Review
facilitated
Product Marketing
Yes
Yes
12
Page states the history condition verbatim: อย่างน้อย 1 ปีขึ้นไป.
geo:tha
EU CE under MDR/IVDR
Abridged Review
facilitated
Product Marketing
Yes
Yes
12
Page states the history condition verbatim: อย่างน้อย 1 ปีขึ้นไป.
geo:tha
Health Canada medical-device licence
Abridged Review
facilitated
Product Marketing
Yes
Yes
12
Page states the history condition verbatim: อย่างน้อย 1 ปีขึ้นไป.
geo:tha
Japan MHLW/PMDA Ninsho or Shonin
Abridged Review
facilitated
Product Marketing
Yes
Yes
12
Page states the history condition verbatim: อย่างน้อย 1 ปีขึ้นไป.
geo:tha
US FDA 510(k), De Novo, or PMA
Abridged Review
facilitated
Product Marketing
Yes
Yes
12
Page states the history condition verbatim: อย่างน้อย 1 ปีขึ้นไป.
geo:tha
Singapore HSA product registration
Assessment Report Reliance
facilitated
Product Marketing
Yes
Yes
Page also states verbatim: อย สามารถเข้าถึง evaluation report ที่ออกโดย HSA สิงคโปร์ได้ (Thai FDA can access the HSA evaluation report).
geo:tha
ASEAN Common Submission Dossier Template
Harmonized Dossier Only
Evidence Only
Dossier Format
Yes
Yes
Thailand is party to the ASEAN agreement on medical-device provisions and aligns controls to it; Thai FDA registration-pathways page confirms submissions use รูปแบบ Common Submission Dossier Template (CSDT) — national registration and decision still required.
Which establishment licences, importer permissions, and distribution controls apply?
An importer must complete importer-establishment registration (จดทะเบียนสถานประกอบการนำเข้า) before it can file medical-device registration applications.
Import of medical devices must pass inspection by officials at medical-device inspection checkpoints (ด่านตรวจสอบเครื่องมือแพทย์) once the checkpoint locations are announced under มาตรา ๖ (๑๗).
Which evidence, local deltas, formats, and signatures are required?
The class-4 licence application must include, among the documents listed in ข้อ ๒, a quality-system certificate (หนังสือรับรองระบบคุณภาพ).
Technical documentation is submitted in the Common Submission Dossier Template (CSDT) format.
Which current form, portal, account, and submission package must be used?
Medical-device registration documents are filed electronically through the SKYNET e-submission system.
Adverse-event and field-safety-corrective-action reports are submitted via the HPVC channel of the SKYNET system, the main channel for receiving forms รมพ. 1, 2 and 3.
Which label and IFU elements, languages, symbols, and translation controls apply?
Registered establishments, licensees, detailed-listing notifiers and notifiers that manufacture or import devices must provide labels and accompanying documents (IFU) that do not show false or exaggerated statements; display follows ministerial-notification criteria, and sellers must ensure labels/IFU are present.
PDF extraction shows กากับ for กำกับ.
The Ministerial Notification on medical-device labelling B.E. 2568 (announced 27 November 2025; Royal Gazette เล่ม 142 ตอนพิเศษ 397 ง, pages 19-24, 22 December 2025) takes effect 20 June 2026.
Gazette reference seen verbatim: ประกาศราชกิจจานุเบกษา เล่ม 142 ตอนพิเศษ 397ง หน้า 19-24.
Which QMS, audit, inspection, and certificate scope is accepted or required?
Import or sale of medical devices must comply with the Ministerial Notification on quality systems for import or sale of medical devices B.E. 2566 (2023).
What review, validation, and applicant stop-clock rules apply?
If a detailed-notification applicant fails to correct the application or supply missing information within the period set by the authority, the applicant is deemed not to wish to proceed and the authority strikes the case from the file register.
Which UDI, device listing, database, and traceability duties apply?
UDI is not yet required in Thailand: the Thai FDA FAQ states that UDI is not currently in use and the implementation timeline is not yet fixed (readiness activities are ongoing).
Which clinical or IVD performance evidence or study is required and accepted?
Devices whose clinical data are insufficient to demonstrate compliance with the essential principles of clinical safety and performance require clinical-investigation data for the clinical evaluation supporting a licence or detailed-notification application; such studies are conducted under IDE permission.
Clinical investigations of medical devices in Thailand must follow ISO 14155:2020 or ISO 20916:2019, as applicable.
Is an emergency, compassionate, custom, humanitarian, or other exceptional path available?
Import of medical devices for individual patients or animals (case-by-case) is exempt from the licensing/notification requirement.
Which PMS plan, report, PMCF or PMPF, trend, and lifecycle-update duties apply?
Four categories of operators (including manufacturers and importers of medical devices) must submit annual reports for the preceding year by 31 March of the following year.
What is reportable, by whom, where, in what format, and by what deadline?
Registered establishments, licensees, detailed-listing notifiers and notifiers must report device malfunctions (ผลการทำงานอันผิดปกติ) and adverse events (เหตุการณ์อันไม่พึงประสงค์) affecting consumers, wherever they occur (domestic or foreign), to the Thai FDA within prescribed periods.
Notification effective 60 days after gazette publication (๗ ธันวาคม ๒๕๖๓).
Events constituting a serious threat to public health must be reported immediately, at the latest within 48 hours of becoming aware.
Events involving death or serious injury must be reported immediately, at the latest within 10 days of becoming aware.
Where scientific data or evidence indicate that recurrence could lead to death or serious injury, the initial report is due within 30 days of awareness; follow-up reports are due within 30 days of submitting the initial report.
Follow-up clause seen verbatim: การรายงานผลการติดตาม ให้รายงานภายในสามสิบวันนับจากวันที่ส่งรายงานเบื้องต้น.
Events occurring outside Thailand are reported twice a year: events in January-June by August, and events in July-December by February, plus any additional reports requested by the Thai FDA; devices produced and sold only in Thailand follow the domestic timelines.
February deadline seen verbatim: ถึงธันวาคม ให้รายงานภายในเดือนกุมภาพันธ์.
Field safety corrective actions (domestic and foreign): initial report within 48 hours of becoming aware that an FSCA will be carried out; follow-up or final report within 21 days of the previous report.
21-day clause seen verbatim: การรายงานผลการติดตามหรือรายงานฉบับสุดท้าย ให้รายงานภายในยี่สิบเอ็ดวันนับจากวันที่รายงานฉบับก่อนหน้านั้น.
Which recall, FSCA, notice, and authority-coordination duties apply?
The Secretary-General of the Thai FDA may order manufacturers, importers or sellers to recall devices from the market within a period the Secretary-General prescribes; the operator bears the costs of the recall and any destruction or disposal ordered.
Which claims, audiences, channels, approvals, and restrictions apply?
Advertising a medical device requires a prior advertising permit (ใบอนุญาตโฆษณาเครื่องมือแพทย์); permit categories cover advertising to the public and advertising by giveaway items (gimmick) versus other forms.
Advertising directed at medical and public-health professionals can be exempted from the advertising permit by ministerial notification, which sets the devices and the criteria, methods and conditions of the exemption.
How are deficiencies answered, clocks handled, and decisions escalated or appealed?
Refusals (non-issuance or non-renewal of establishment registration, licence, detailed-listing receipt or notification receipt) may be appealed in writing to the Minister within 30 days of receiving notice; the Minister's decision is final, and for non-renewal appeals the Minister may allow the operator to continue business pending decision.
Finality clause seen verbatim: คาวินิจฉัยของรัฐมนตรีให้เป็นที่สุด. Suspension/revocation orders are separately appealable and not automatically stayed.
When a detailed-notification application is refused, the authority must send written notice to the applicant with the reasons and appeal rights within 15 days of the refusal order.

